PB
Peter Blume-Jensen
DELAYED 1 MONTH
Director, President and CEO
Acrivon Therapeutics, Inc.
Filings
4
Companies
1
Latest
May 21, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.
Peter Blume-Jensen
Director, President and CEO
Filings
4
Companies
1
Latest
May 21, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.